- Home
- RLYB vs FSEA Comparison
RLYB vs FSEA Comparison
Compare RLYB & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- FSEA
- Stock Information
- Founded
- RLYB 2018
- FSEA 1890
- Country
- RLYB United States
- FSEA United States
- Employees
- RLYB N/A
- FSEA N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- FSEA Savings Institutions
- Sector
- RLYB Health Care
- FSEA Finance
- Exchange
- RLYB Nasdaq
- FSEA Nasdaq
- Market Cap
- RLYB 46.1M
- FSEA 44.2M
- IPO Year
- RLYB 2021
- FSEA N/A
- Fundamental
- Price
- RLYB $1.11
- FSEA $8.95
- Analyst Decision
- RLYB Buy
- FSEA
- Analyst Count
- RLYB 6
- FSEA 0
- Target Price
- RLYB $8.30
- FSEA N/A
- AVG Volume (30 Days)
- RLYB 50.0K
- FSEA 18.7K
- Earning Date
- RLYB 11-07-2024
- FSEA 11-07-2024
- Dividend Yield
- RLYB N/A
- FSEA N/A
- EPS Growth
- RLYB N/A
- FSEA N/A
- EPS
- RLYB N/A
- FSEA N/A
- Revenue
- RLYB $299,000.00
- FSEA $10,821,000.00
- Revenue This Year
- RLYB N/A
- FSEA N/A
- Revenue Next Year
- RLYB N/A
- FSEA N/A
- P/E Ratio
- RLYB N/A
- FSEA N/A
- Revenue Growth
- RLYB N/A
- FSEA N/A
- 52 Week Low
- RLYB $1.08
- FSEA $6.25
- 52 Week High
- RLYB $4.60
- FSEA $9.49
- Technical
- Relative Strength Index (RSI)
- RLYB 47.41
- FSEA 36.68
- Support Level
- RLYB $1.09
- FSEA $9.00
- Resistance Level
- RLYB $1.18
- FSEA $9.15
- Average True Range (ATR)
- RLYB 0.04
- FSEA 0.07
- MACD
- RLYB 0.00
- FSEA -0.02
- Stochastic Oscillator
- RLYB 22.22
- FSEA 14.00
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.